Skip to main content
. 2018 May 7;22(1):127–133. doi: 10.3233/CBM-171103

Figure 3.

Figure 3.

A. The association between serum miR-101 levels and therapeutic response for all patients. B. The association between serum miR-101 levels and therapeutic response for the patients without metastasis. C. The association between serum miR-101 levels and therapeutic response for the patients with metastasis.